New study aims to uncover what cirrhosis patients really need
NCT ID NCT07273331
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at the quality of life, disease knowledge, and nursing needs of 150 adults with liver cirrhosis who visit the outpatient clinic at Landspitali University Hospital in Iceland. Participants will fill out three questionnaires and give a blood sample. The goal is to learn how to better support patients and improve their care.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- What this could lead to
- If successful, this study could help doctors and nurses better understand what patients with cirrhosis need, leading to improved care plans and support.
- What could go wrong
- This is an observational study that does not test a new treatment. It only collects information through questionnaires and blood samples, so it cannot directly improve health.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
About 150 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Nov 2025
- Expected to finish
-
Dec 2028
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
Patients with cirrhosis in outpatient clinic at Landspitali
- Ages
-
Children (under 18), adults (18 to 64) and older adults (65 and over)
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Participants eligible for enrolment must meet the following criteria: * Be 18 years of age or older * Have a confirmed diagnosis of liver cirrhosis * Be fluent in Icelandic or English, to ensure participants can comprehend study materials and provide informed consent. These criteria are designed to ensure that participants can meaningfully engage with the study procedures and provide reliable patient-reported data. Exclusion Criteria:Participants will be excluded from the study if they meet any of the following conditions: * Exhibit severe cognitive impairment that may interfere with informed consent or the completion of questionnaires * Are experiencing acute or severe illness at the time of recruitment, such as recent hospitalization due to hepatic encephalopathy or bleeding from esophageal varices These exclusion criteria are intended to protect vulnerable individuals and maintain the integrity of the data collected.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Cirrhoses, liver are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
2 sites. The list below names each one and where it is.
-
The official record
The full official record for this study. This one lists no contact details, but it is the first place any would appear.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Eirberg Eiríksgata 34
Reykjavik, 105, Iceland
-
Faculty of Nursing and Midwifery
Reykjavik, 105, Iceland
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a gout drug stop cirrhosis from getting worse?
- Can a common gout drug shield the liver from cirrhosis complications?
- Can coaching and walking ease pain in liver disease?
- A simple scan and blood test could catch silent liver scarring before It's too late
- Can tracking hospital care for liver patients reduce repeat admissions?
- 300 cirrhosis patients join study to uncover hidden triggers of liver cancer